The spectrum of Pediatric scarring alopecia, finds Study
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
There are few studies examining pediatric scarring alopecia. The objective of this study is to characterize the clinicopathologic findings, comorbidities, and treatment outcomes of pediatric patients with scarring alopecia. Retrospective review was done of patients under age 18 diagnosed with scarring alopecia.

Results:
--27 patients met inclusion criteria with a mean age of 11.2 years and a racial breakdown of 85.2% White, 11.1% Black, and 3.7% Multiracial.

--Clinical scarring was noted in most (23). Biopsy confirmed the diagnosis in most (24).

--The most common diagnoses were folliculitis decalvans (6), lichen planopilaris (6), aplasia cutis congenita (4), tinea capitis (4), and morphea (3).

--Comorbid depression (6) and anxiety (6) were prevalent.

--Of the patients who received follow-up, most who pursued treatment achieved stabilization (55.5%) or slowing of progression (27.8%), with 44.4% of those treated experiencing regrowth.

--Mean time to stabilization in the treated population was 19.6 months.

--2 patients did not pursue treatment, but received follow-up and these untreated patients did not experience hair regrowth.

Finally, the majority of patients had clinically obvious primary scarring alopecia. A biopsy may be needed to confirm the diagnosis. Active therapy should be sought, and effective treatment also necessitates the use of multiple treatments. It can take years for a situation to stabilize. Depression and anxiety screening should be sought.

Source: https://onlinelibrary.wiley.com/doi/10.1111/pde.14543
Like
Comment
Share